Skip to content
  • About Us
  • Investment Focus
  • Team
  • Portfolio
  • News
  • Contact Us
Foamix Pharmaceuticals Ltd. Announces Upsizing and Pricing of its $60 Million Public Offering of Ordinary Shares

Foamix Pharmaceuticals Ltd. Announces Upsizing and Pricing of its $60 Million Public Offering of Ordinary Shares